← Back to headlines
NanoViricides Advances Oral Ebola Gummies Towards DRC Trial
NanoViricides is moving its NV-387 oral gummies forward for an Ebola trial in the Democratic Republic of Congo.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
